Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies

British Journal of Cancer
D GorenA A Gabizon

Abstract

Long-circulating (stealth) liposomes coated with polyethylene glycol (PEG), which show reduced uptake by the reticuloendothelial system (RES) and enhanced accumulation in tumours, were used for conjugation to monoclonal antibodies (MAbs) as a drug-targeting device. A MAb (N-12A5) directed against erbB-2 oncoprotein, a functional surface antigen, was used. Amplification and overexpression of the erbB-2 gene product, being unique to malignancy, confer onto this antibody-mediated therapy high tumour specificity. In vitro binding of [3H]cholesteryl ether ([3H]Chol ether) labelled anti-erbB-2 conjugated liposomes to N-87 cells (erbB-2-positive human gastric carcinoma) was compared with the binding of non-targeted liposomes and indicated a 16-fold increase in binding for the targeted liposomes. No difference in binding to OV1063 cells (erbB-2-negative human ovary carcinoma) was observed. These results indicate highly selective binding of antibody-targeted liposomes to erbB-2-overexpressing cells. Despite increased cell binding, doxorubicin (DOX) loaded in anti-erbB-2-conjugated liposomes did not cause increased in vitro cytotoxicity against N-87 cells, suggesting lack of liposome internalisation. In vivo, the critical factor needed t...Continue Reading

Citations

Mar 4, 2003·Journal of Cellular and Molecular Medicine·Manuela Voinea, Maya Simionescu
Jul 23, 2004·Expert Opinion on Therapeutic Targets·Charles O NobleDaryl C Drummond
Sep 6, 2006·Journal of Liposome Research·Alberto A GabizonSamuel Zalipsky
Dec 31, 2014·International Journal of Molecular Sciences·Huei Leng Helena NgZhijun Yang
Jan 14, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Mahfoozur RahmanFiroz Anwar
Sep 4, 2015·Nanomedicine·Lijuan GuanGiuseppe Battaglia
Sep 19, 2019·Expert Opinion on Drug Delivery·Ludger M Ickenstein, Patrick Garidel
Jan 5, 2002·Expert Opinion on Investigational Drugs·K J Harrington
Feb 5, 2002·Biological & Pharmaceutical Bulletin·Atsuo OnoMasaharu Ueno
May 5, 2007·Expert Opinion on Biological Therapy·Ernst Wagner
Mar 15, 2012·The AAPS Journal·Rupa R Sawant, Vladimir P Torchilin
Mar 6, 2012·Nanomedicine·Hasmik AgadjanianLali K Medina-Kauwe
Jan 28, 2006·Journal of Cellular Biochemistry·T C Yih, M Al-Fandi
Jan 7, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shuxian SongYuhong Xu
Jan 15, 2009·Angewandte Chemie·Kristina RiehemannHarald Fuchs
Sep 18, 2009·Journal of the Royal Society, Interface·Shan JiangYong Zhang
Nov 4, 2017·Journal of Drug Targeting·Kıvılcım Öztürk-AtarSema Çalış
Dec 14, 2018·The Journal of Pharmacology and Experimental Therapeutics·Manisit Das, Leaf Huang
Feb 1, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Luca DigiacomoGiulio Caracciolo
Feb 12, 2011·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Vadzim ReshetovLina Bezdetnaya
Feb 2, 2010·Pediatric Research·Noah Federman, Christopher T Denny
Jul 31, 2012·Therapeutic Delivery·Hunghao Chu, Yadong Wang
Nov 21, 2007·Molecular Cancer Therapeutics·Sajid HussainUwe Zangemeister-Wittke
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Puja Sapra, Theresa M Allen
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomonori ShiokawaYoshie Maitani
Jun 12, 2020·Advanced Drug Delivery Reviews·Alberto A GabizonNinh M La-Beck
May 18, 2001·Journal of Pharmaceutical Sciences·T Lian, R J Ho
Aug 1, 2000·Pharmaceutical Science & Technology Today·U B Nielsen, J D Marks
Jun 6, 2000·Advanced Drug Delivery Reviews·M C Woodle
Nov 24, 2001·Biochimica Et Biophysica Acta·J N MoreiraT M Allen
Jul 25, 1997·Biochimica Et Biophysica Acta·J A HardingS Zalipsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.